Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study
2019 ◽
Vol 24
(11)
◽
pp. 1449-1458
◽
2020 ◽
Vol 25
(4)
◽
pp. 782-783
2016 ◽
Vol 22
(3)
◽
pp. S285